Liberty One Investment Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-181
| Closed | -$2.83K | – | 172 |
|
2024
Q3 | $2.83K | Sell |
181
-1,077
| -86% | -$16.8K | ﹤0.01% | 163 |
|
2024
Q2 | $22K | Buy |
1,258
+14
| +1% | +$245 | ﹤0.01% | 158 |
|
2024
Q1 | $19.4K | Buy |
1,244
+52
| +4% | +$813 | ﹤0.01% | 168 |
|
2023
Q4 | $17.8K | Buy |
1,192
+1,032
| +645% | +$15.4K | ﹤0.01% | 145 |
|
2023
Q3 | $2.58K | Buy |
160
+38
| +31% | +$614 | ﹤0.01% | 160 |
|
2023
Q2 | $5.06K | Hold |
122
| – | – | ﹤0.01% | 164 |
|
2023
Q1 | $7.34K | Buy |
+122
| New | +$7.34K | ﹤0.01% | 152 |
|
2022
Q2 | – | Sell |
-15
| Closed | -$1K | – | 154 |
|
2022
Q1 | $1K | Buy |
+15
| New | +$1K | ﹤0.01% | 162 |
|